| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 219.01B | 210.75B | 195.44B | 174.11B | 163.37B | 151.94B |
| Gross Profit | 55.57B | 54.03B | 50.09B | 44.31B | 40.87B | 38.11B |
| EBITDA | 17.07B | 17.11B | 15.54B | 13.14B | 12.61B | 11.21B |
| Net Income | 9.00B | 8.91B | 8.59B | 6.20B | 5.93B | 5.50B |
Balance Sheet | ||||||
| Total Assets | 132.75B | 114.01B | 104.79B | 99.52B | 87.64B | 91.21B |
| Cash, Cash Equivalents and Short-Term Investments | 28.27B | 15.03B | 18.14B | 17.84B | 14.66B | 23.25B |
| Total Debt | 11.30B | 11.13B | 15.14B | 19.44B | 14.09B | 16.89B |
| Total Liabilities | 59.27B | 43.58B | 42.27B | 44.71B | 38.23B | 46.99B |
| Stockholders Equity | 73.48B | 70.43B | 62.51B | 54.81B | 49.40B | 44.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.88B | 6.35B | -176.00M | -4.33B | 5.20B |
| Operating Cash Flow | 0.00 | 15.89B | 13.15B | 10.62B | 3.28B | 11.59B |
| Investing Cash Flow | 0.00 | -13.76B | -7.25B | -11.52B | -7.82B | -7.56B |
| Financing Cash Flow | 0.00 | -5.25B | -5.60B | 4.08B | -4.05B | 4.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥112.33B | 16.52 | ― | 1.92% | 2.30% | 26.52% | |
76 Outperform | ¥156.08B | 15.86 | ― | 1.64% | 10.13% | 23.77% | |
72 Outperform | ¥92.55B | 10.82 | ― | 1.47% | 7.75% | -1.68% | |
72 Outperform | ¥217.59B | 15.19 | ― | 2.43% | 4.48% | 13.17% | |
71 Outperform | ¥71.86B | 11.40 | ― | 1.34% | 20.50% | 10.77% | |
66 Neutral | ¥31.84B | 14.62 | ― | 2.22% | 7.94% | -8.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |